Jan Lašťovička

603 total citations
14 papers, 456 citations indexed

About

Jan Lašťovička is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Jan Lašťovička has authored 14 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Jan Lašťovička's work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Jan Lašťovička is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Jan Lašťovička collaborates with scholars based in Czechia and France. Jan Lašťovička's co-authors include Jiřina Bartůňková, Radek Špíšek, Tomáš Kalina, Jan Havlín, Daniela Rožková, Robert Lischke, Petr Hubáček, Rudolf Horváth, Jana Kayserová and L. Jarolím and has published in prestigious journals such as Frontiers in Immunology, Oncotarget and Clinical & Experimental Immunology.

In The Last Decade

Jan Lašťovička

14 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Lašťovička Czechia	11	248	126	115	79	71	14	456
Jennifer Bassett Canada	10	263 1.1×	139 1.1×	40 0.3×	99 1.3×	76 1.1×	10	512
Yannic C. Bartsch United States	11	239 1.0×	21 0.2×	222 1.9×	139 1.8×	32 0.5×	24	537
B. Samuel Lundin Sweden	10	337 1.4×	56 0.4×	61 0.5×	78 1.0×	27 0.4×	12	520
Laura A. Vella United States	12	329 1.3×	95 0.8×	98 0.9×	157 2.0×	37 0.5×	19	609
Stella G. Hoft United States	11	157 0.6×	56 0.4×	87 0.8×	85 1.1×	29 0.4×	17	377
Toru Aoyama Japan	9	85 0.3×	70 0.6×	80 0.7×	157 2.0×	74 1.0×	28	553
Shay Leary Australia	10	117 0.5×	51 0.4×	96 0.8×	62 0.8×	30 0.4×	26	304
Alice Banz France	14	362 1.5×	37 0.3×	215 1.9×	150 1.9×	39 0.5×	24	767
Jeong-Hee Lee South Korea	9	1.1k 4.4×	106 0.8×	99 0.9×	137 1.7×	40 0.6×	19	1.4k
Shoji Yokochi Japan	8	182 0.7×	156 1.2×	186 1.6×	70 0.9×	38 0.5×	12	459

Countries citing papers authored by Jan Lašťovička

Since Specialization

Citations

This map shows the geographic impact of Jan Lašťovička's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lašťovička with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lašťovička more than expected).

Fields of papers citing papers by Jan Lašťovička

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lašťovička. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lašťovička. The network helps show where Jan Lašťovička may publish in the future.

Co-authorship network of co-authors of Jan Lašťovička

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lašťovička. A scholar is included among the top collaborators of Jan Lašťovička based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lašťovička. Jan Lašťovička is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Stakheev, Dmitry, et al.. (2022). Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy. Frontiers in Immunology. 13. 892277–892277. 10 indexed citations

Milota, Tomáš, Jitka Smetanová, Jan Lašťovička, et al.. (2022). Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency. The Journal of Allergy and Clinical Immunology In Practice. 11(1). 306–314.e2. 8 indexed citations

Havlín, Jan, et al.. (2021). Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients. The Journal of Heart and Lung Transplantation. 40(8). 754–758. 87 indexed citations

Lašťovička, Jan, et al.. (2021). SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors. Immunity Inflammation and Disease. 9(4). 1452–1467. 9 indexed citations

Lašťovička, Jan, et al.. (2016). Assessment of lymphocyte proliferation for diagnostic purpose: Comparison of CFSE staining, Ki-67 expression and 3H-thymidine incorporation. Human Immunology. 77(12). 1215–1222. 28 indexed citations

Horváth, Rudolf, Étienne Becht, Daniela Rožková, et al.. (2015). Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. Oncotarget. 6(20). 18192–18205. 109 indexed citations

Brtnický, Tomáš, Anna Fialová, Jan Lašťovička, Lukáš Rob, & Radek Špíšek. (2014). Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients. Human Immunology. 76(2-3). 187–191. 11 indexed citations

Lašťovička, Jan, Jana Kayserová, Radek Špíšek, et al.. (2013). Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma. Immunology Letters. 152(2). 144–150. 29 indexed citations

Nevoral, J, Radana Kotalová, Ondřej Hradský, et al.. (2013). Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines. European Journal of Pediatrics. 173(4). 497–502. 25 indexed citations

10.

Lašťovička, Jan. (2013). The Phenotypic Markers of CD4+CD25+ T Regulatory Lymphocytes. 1–14. 15 indexed citations

11.

Horváth, Rudolf, Daniela Rožková, Jan Lašťovička, et al.. (2011). Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease. Clinical & Experimental Immunology. 166(1). 26–33. 26 indexed citations

12.

Lašťovička, Jan, et al.. (2009). Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cellular Immunology. 256(1-2). 79–85. 70 indexed citations

13.

Rožková, Daniela, Jitka Fučíková, Jan Lašťovička, et al.. (2009). FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer. Clinical Immunology. 131(1). 1–10. 28 indexed citations

14.

Bubeník, J, et al.. (1981). Electrophoretic mobility profiles of mouse leukemias: I. Electrophoresis of normal mouse thymus and lymph node cell populations.. PubMed. 28(5). 517–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact